4.7 Article

Toward an optimal blood-brain barrier shuttle by synthesis and evaluation of peptide libraries

期刊

JOURNAL OF MEDICINAL CHEMISTRY
卷 51, 期 16, 页码 4881-4889

出版社

AMER CHEMICAL SOC
DOI: 10.1021/jm800156z

关键词

-

资金

  1. MCYT-FEDER [BIO 2005-00295]
  2. Generalitat de Catalunya [2005SGR-00663]

向作者/读者索取更多资源

Several peptide families containing N-methylated amino acids were designed and synthesized using solid-phase peptide synthesis (SPPS). The permeability and phospholipophilicity of these compounds were studied by parallel artificial membrane permeability assay (PAMPA) and immobilized artificial membrane chromatography (IAMC) to select the best peptides in terms of length, terminal groups, and amino acid replacement to be used as carriers that pass through a model of the blood-brain barrier (BBB) by passive diffusion. Furthermore, the enzymatic stability of these peptides in human serum and their cell viability by MTT assay were tested. These peptide families showed great stability and nontoxicity. The three peptides that showed the greatest permeability were Coupled to levodopa (a nonpassive permeating drug) and assessed. These peptides effectively transferred levodopa through an artificial membrane by means of passive diffusion.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Multidisciplinary

Self-Assembly of DNA-Peptide Supermolecules: Coiled-Coil Peptide Structures Templated by d-DNA and l-DNA Triplexes Exhibit Chirality-Independent but Orientation-Dependent Stabilizing Cooperativity

Chenguang Lou, Josephine Tuborg Boesen, Niels Johan Christensen, Kasper K. Sorensen, Peter W. Thulstrup, Martin Nors Pedersen, Ernest Giralt, Knud J. Jensen, Jesper Wengel

CHEMISTRY-A EUROPEAN JOURNAL (2020)

Article Chemistry, Medicinal

Development of Brain Targeting Peptide Based MMP-9 Inhibiting Nanoparticles for the Treatment of Brain Diseases with Elevated MMP-9 Activity

Yamir Islam, Aneesa Khalid, Stefano Pluchino, Muttuswamy Sivakumaran, Meritxell Teixido, Andrew Leach, Amos A. Fatokun, James Downing, Christopher Coxon, Touraj Ehtezazi

JOURNAL OF PHARMACEUTICAL SCIENCES (2020)

Article Chemistry, Multidisciplinary

Adrenergic Modulation With Photochromic Ligands

Davia Prischich, Alexandre M. J. Gomila, Santiago Milla-Navarro, Gemma Sanguesa, Rebeca Diez-Alarcia, Beatrice Preda, Carlo Matera, Montserrat Batlle, Laura Ramirez, Ernest Giralt, Jordi Hernando, Eduard Guasch, J. Javier Meana, Pedro de la Villa, Pau Gorostiza

Summary: The paper introduces a first generation of photochromic ligands that can modulate physiological processes by manipulating adrenergic neurotransmission, demonstrating their control effects in zebrafish and mice.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Article Chemistry, Physical

Amphiphilic Polymeric Nanoparticles Modified with a Retro-Enantio Peptide Shuttle Target the Brain of Mice

Alexandra Bukchin, Macarena Sanchez-Navarro, Adam Carrera, Meritxell Teixido, Angel M. Carcaboso, Ernest Giralt, Alejandro Sosnik

CHEMISTRY OF MATERIALS (2020)

Article Chemistry, Multidisciplinary

The Combined Use of Gold Nanoparticles and Infrared Radiation Enables Cytosolic Protein Delivery

Josep Garcia, J. Marcos Fernandez-Pradas, Anna Llado, Pere Serra, Dobryna Zalvidea, Marcelo J. Kogan, Ernest Giralt, Macarena Sanchez-Navarro

Summary: By utilizing the unique photothermal properties of gold nanorods, combined with modifications of cell-penetrating peptide and nuclear targeting on proteins and AuNRs, and achieving spatiotemporal control of protein release within the safe biological window through near-infrared laser irradiation, cytosolic protein delivery has been successfully triggered.

CHEMISTRY-A EUROPEAN JOURNAL (2021)

Article Chemistry, Medicinal

The Inclusion of a Matrix Metalloproteinase-9 Responsive Sequence in Self-assembled Peptide-based Brain-Targeting Nanoparticles Improves the Efficiency of Nanoparticles Crossing the Blood-Brain Barrier at Elevated MMP-9 Levels

Yamir Islam, Parinaz Ehtezazi, Andrew Cashmore, Elena Marinsalda, Andrew G. Leach, Christopher R. Coxon, Amos A. Fatokun, Darren W. Sexton, Iftikhar Khan, Georgios Zouganelis, James Downing, Stefano Pluchino, Muttuswamy Sivakumaran, Meritxell Teixido, Touraj Ehtezazi

Summary: The study investigated whether including MMP-9-sensitive sequences in brain-targeting nanoparticles could enhance BBB penetration during elevated MMP-9 levels, leading to increased transport across the BBB model when MMP-9 levels were elevated and the brain-targeting ligand was responsive to MMP-9.

JOURNAL OF PHARMACEUTICAL SCIENCES (2021)

Review Pharmacology & Pharmacy

Brain metastasis models: What should we aim to achieve better treatments?

M. Masmudi-Martin, L. Zhu, M. Sanchez-Navarro, N. Priego, M. Casanova-Acebes, V. Ruiz-Rodado, E. Giralt, M. Valiente

Summary: Brain metastasis is a unique entity in oncology with specific biological characteristics and different pharmacological approaches. Despite pre-clinical evidence demonstrating vulnerabilities, many clinical trials have excluded patients with brain metastasis. Emerging trends and unsolved issues will shape the study of experimental brain metastasis in the future.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Article Microbiology

AOA-2 Derivatives as Outer Membrane Protein A Inhibitors for Treatment of Gram-Negative Bacilli Infections

Rafael Ayerbe-Algaba, Nuria Bayo, Ester Verdu, Raquel Parra-Millan, Jesus Seco, Meritxell Teixido, Jeronimo Pachon, Ernest Giralt, Younes Smani

Summary: In this study, ten AOA-2 derivatives were synthesized and evaluated for their effects against Gram-negative bacilli infections. Among them, RW01 and RW06 showed promising potential in improving the inhibitory effect of AOA-2, specifically against Pseudomonas aeruginosa and Escherichia coli by reducing bacterial adherence to host cells while slightly improving the viability of infected cells. Additionally, RW01 and RW06 also potentiated the activity of colistin against Acinetobacter baumannii strain, highlighting their potential as effective antimicrobial agents.

FRONTIERS IN MICROBIOLOGY (2021)

Review Chemistry, Multidisciplinary

Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles

Yamir Islam, Andrew G. Leach, Jayden Smith, Stefano Pluchino, Christopher R. Coxon, Muttuswamy Sivakumaran, James Downing, Amos A. Fatokun, Meritxell Teixido, Touraj Ehtezazi

Summary: The prevalence of neurological/neurodegenerative diseases, such as Alzheimer's disease, is increasing due to an aging population, posing challenges for treatment as therapeutic agents struggle to reach the brain. Brain physiology changes during diseases and aging, potentially increasing blood-brain barrier permeability, making drug delivery to the diseased brain even more complex. New approaches using nanoparticles or magnetic resonance imaging guided systems have been discussed for delivering therapeutic agents to the brain, while also considering complement activation, toxicity, and immunogenicity of brain targeting nanoparticles.

ADVANCED SCIENCE (2021)

Article Chemistry, Medicinal

Peptide-Platinum(IV) Conjugation Minimizes the Negative Impact of Current Anticancer Chemotherapy on Nonmalignant Cells

Jenniffer Linares, Monica Varese, Anna Sallent-Aragay, Ana Mendez, Sergio Palomo-Ponce, Mar Iglesias, Eduard Batlle, Jorge Pisonero, Clara Montagut, Ernest Giralt, Daniele Lo Re, Alexandre Calon

Summary: We report the synthesis of a novel Pt(IV) cell-penetrating peptide conjugate, C-POC, with reduced impact on nonmalignant cells. In vitro and in vivo evaluation showed that C-POC maintains robust anticancer efficacy while reducing accumulation in healthy organs and adverse toxicity compared to standard Pt-based therapy. Our findings highlight the importance of considering the off-target impact of anticancer treatment on normal cells for improved drug development and patient care.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Multidisciplinary

Target-templated de novo design of macrocyclic d-/l-peptides: discovery of drug-like inhibitors of PD-1

Salvador Guardiola, Monica Varese, Xavier Roig, Macarena Sanchez-Navarro, Jesus Garcia, Ernest Giralt

Summary: This study presents a method for designing heterochiral cyclic peptides that bind to a specific protein surface, as well as the development and biophysical evaluation of two new PD-1 inhibitors.

CHEMICAL SCIENCE (2021)

Article Nanoscience & Nanotechnology

Amphiphilic Polymeric Nanoparticles Modified with a Protease-Resistant Peptide Shuttle for the Delivery of SN-38 in Diffuse Intrinsic Pontine Glioma

Alexandra Bukchin, Macarena Sanchez-Navarro, Adam Carrera, Claudia Resa-Pares, Helena Castillo-Ecija, Leire Balaguer-Lluna, Meritxell Teixido, Nagore G. Olaciregui, Ernest Giralt, Angel M. Carcaboso, Alejandro Sosnik

Summary: The study developed modified drug-loaded nanoparticles that can enhance transport across the blood-brain barrier and display anticancer activity in DIPG cells. These nanoparticles are mainly internalized by DIPG cells through clathrin-mediated endocytosis and show strong anticancer efficacy in vivo by killing a substantial amount of DIPG cells.

ACS APPLIED NANO MATERIALS (2021)

Article Materials Science, Biomaterials

In vivo micro computed tomography detection and decrease in amyloid load by using multifunctionalized gold nanorods: a neurotheranostic platform for Alzheimer's disease

Francisco Morales-Zavala, Pedro Jara-Guajardo, David Chamorro, Ana L. Riveros, America Chandia-Cristi, Nicole Salgado, Paola Pismante, Ernest Giralt, Macarena Sanchez-Navarro, Eyleen Araya, Rodrigo Vasquez, Gerardo Acosta, Fernando Albericio, Alejandra R. Alvarez, Marcelo J. Kogan

Summary: In this study, a neurotheranostic nanosystem based on gold nanorods was developed for the treatment of Alzheimer's disease. Functionalized gold nanorods were able to detect differences between wild type and AD mice, and showed promising therapeutic effects in reducing amyloid load and inflammatory markers in the brain after recurrent treatment.

BIOMATERIALS SCIENCE (2021)

暂无数据